BioCentury
ARTICLE | Clinical News

Latanoprost punctal plug delivery system: Additional Phase II data

March 15, 2010 7:00 AM UTC

Additional data from an open-label Phase II trial in 113 patients showed that 44 and 81 µg latanoprost delivered via punctal plug did not meet the trial's objective of reducing mean IOP by >=5 mmHg fr...